Crane NXT Co's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Crane NXT Co reported revenue of $1.7B (+11.4% year on year) and net income of $145.1M.
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net sales | $1.7B | $1.5B | $1.4B | $3.4B |
| Cost of sales | $952.9M | $821.7M | $737.2M | $2.0B |
| Selling, general and administrative | $440.3M | $386.2M | $366.8M | $797.5M |
| Restructuring charges | $16.8M | $10.1M | $500.0K | $10.4M |
| Operating profit | $246.7M | $268.8M | $286.8M | $369.5M |
| Interest income | $1.0M | $1.6M | $1.1M | $3.4M |
| Interest expense | $60.3M | $47.8M | ($50.6M) | ($52.2M) |
| Equity investment (loss) gain | ($11.5M) | — | — | — |
| Miscellaneous income, net | $5.1M | $3.8M | $2.5M | $9.8M |
| Total other expense, net | ($65.7M) | ($42.4M) | ($47.0M) | $193.5M |
| Income before income taxes | $181.0M | $226.4M | $239.8M | $563.0M |
| Provision for income taxes | $35.9M | $42.3M | $51.5M | $161.9M |
| Net income before allocation to noncontrolling interest | $145.1M | $184.1M | $188.3M | $401.1M |
| Net Income (Loss) Attributable to Noncontrolling Interest | $0 | — | — | $0 |
| Basic (in dollars per share) | $2.53 | $3.22 | $3.31 | $7.11 |
| Diluted (in dollars per share) | $2.50 | $3.19 | $3.28 | $7.01 |
| Basic (in shares) | 57.4M | 57.1M | 56.8M | 56.4M |
| Diluted (in shares) | 58.0M | 57.8M | 57.5M | 57.2M |
| Net income | $145.1M | — | — | $401.1M |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Net sales | $493.2M | $387.7M | $445.1M | $404.4M |
| Cost of sales | $284.6M | $231.8M | $252.5M | $235.6M |
| Selling, general and administrative | $136.3M | $130.6M | $107.2M | $113.6M |
| Restructuring charges | $3.4M | $3.1M | $3.5M | $7.3M |
| Operating profit | $68.9M | $22.2M | $81.9M | $47.9M |
| Interest expense | ($21.0M) | ($17.8M) | ($16.2M) | ($16.4M) |
| Income (Loss) from Equity Method Investments | $100.0K | $4.7M | — | — |
| Miscellaneous (expense) income, net | $100.0K | $100.0K | $600.0K | $1.1M |
| Total other expense, net | ($21.0M) | ($13.0M) | ($15.3M) | ($15.1M) |
| Income before income taxes | $47.9M | $9.2M | $66.6M | $32.8M |
| Provision for income taxes | $11.7M | $2.4M | $15.7M | $7.8M |
| Net income before allocation to noncontrolling interest | $36.2M | $6.8M | $50.9M | $25.0M |
| Net Income (Loss) Attributable to Noncontrolling Interest | $800.0K | $400.0K | $400.0K | $100.0K |
| Net income attributable to common shareholders | $35.4M | $6.4M | $50.5M | $24.9M |
| Basic (in dollars per share) | $0.61 | $0.11 | $0.88 | $0.43 |
| Diluted (in dollars per share) | $0.61 | $0.11 | $0.87 | $0.43 |
| Basic (in shares) | 57.5M | 57.5M | 57.4M | 57.4M |
| Diluted (in shares) | 58.0M | 58.0M | 58.0M | 57.9M |
| Dividends per share (in dollars per share) | $0.18 | $0.18 | $0.17 | $0.17 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $233.8M | $165.8M | $227.2M | $657.6M |
| Accounts receivable, net | $351.8M | $265.9M | $214.9M | $474.7M |
| U.S. and foreign taxes on income | $12.7M | $8.6M | — | — |
| Inventories, net | $169.5M | $144.8M | $157.1M | $439.8M |
| Other current assets | $85.1M | $57.4M | $45.2M | $179.8M |
| Total current assets | $852.9M | $642.5M | $644.4M | $1.8B |
| Property, plant and equipment, net | $303.8M | $272.3M | $261.2M | $509.9M |
| Long-term deferred tax assets | $2.5M | $2.2M | $2.7M | $8.3M |
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | $139.4M | — | — | — |
| Intangible assets, net | $557.2M | $419.3M | $308.9M | $416.6M |
| Goodwill | $1.2B | $956.6M | $841.2M | $1.5B |
| Other assets | $96.6M | $93.6M | $71.0M | $176.0M |
| Total assets | $3.1B | $2.4B | $2.1B | $4.4B |
| Short-term borrowings | $135.1M | $210.0M | $4.6M | $699.3M |
| Accounts payable | $132.3M | $116.6M | $106.5M | $286.6M |
| Accrued liabilities | $273.0M | $211.2M | $210.5M | $464.2M |
| U.S. and foreign taxes on income | $28.7M | $24.6M | $12.8M | $38.1M |
| Total current liabilities | $569.1M | $562.4M | $334.4M | $1.5B |
| Long-term debt | $1.0B | $540.6M | $640.3M | $543.7M |
| Accrued pension and postretirement benefits | $19.1M | $19.4M | $22.5M | $153.2M |
| Long-term deferred tax liability | $151.0M | $119.0M | $104.5M | $162.4M |
| Other liabilities | $116.0M | $80.2M | $63.7M | $138.7M |
| Total liabilities | $1.9B | $1.3B | $1.2B | — |
| Redeemable noncontrolling Interests | $6.9M | — | — | — |
| Preferred shares, par value 0.01; 5,000,000 shares authorized | 0 | 0 | 0 | 0 |
| Common shares, par value $1.00; 200,000,000 shares authorized; 72,441,647 shares issued; 57,441,541 shares and 57,197,147 shares outstanding as of December 31, 2025 and 2024, respectively | 72.4M | 72.4M | 72.4M | 72.4M |
| Capital surplus | $1.7B | $1.7B | $1.7B | $373.8M |
| Retained earnings | $374.5M | $268.4M | $120.9M | $2.8B |
| Accumulated other comprehensive loss | ($99.9M) | ($172.6M) | ($118.6M) | ($503.3M) |
| Treasury stock; 15,000,106 and 15,244,500 treasury shares as of December 31, 2025 and 2024, respectively | -810.5M | -823.2M | -838.8M | — |
| Total shareholders’ equity | $1.3B | $1.1B | $964.0M | $1.9B |
| Nonredeemable noncontrolling interests | ($3.1M) | — | — | $2.6M |
| Total equity | $1.2B | — | — | $1.9B |
| Total liabilities, redeemable noncontrolling interests, and equity | $3.1B | $2.4B | $2.1B | $4.4B |
| Common shares, outstanding (in shares) | 57.4M | — | — | — |
| Preferred shares, authorized (in shares) | 5.0M | — | — | — |
| Preferred shares, par value (in dollars per share) | $0.01 | — | — | — |
| Common shares, authorized (in shares) | 200.0M | — | — | — |
| Common shares, par value (in dollars per share) | $1.00 | — | — | — |
| Common shares, issued (in shares) | 72.4M | — | — | — |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $231.4M | $228.3M | $182.4M | $152.5M |
| Accounts receivable, net of allowance for credit losses of $11.2 as of June 30, 2026 and $8.9 as of December 31, 2025 | $406.9M | $420.0M | $300.7M | $308.8M |
| U.S. and foreign taxes on income | $18.9M | $14.1M | $9.3M | $16.2M |
| Finished goods | $65.8M | $77.1M | $38.3M | $43.7M |
| Finished parts and subassemblies | $30.5M | $32.6M | $26.4M | $22.5M |
| Work in process | $31.6M | $34.1M | $23.7M | $31.1M |
| Raw materials | $110.6M | $116.7M | $107.5M | $93.0M |
| Inventories, net: | $238.5M | $260.5M | $195.9M | $190.3M |
| Other current assets | $84.8M | $91.2M | $82.3M | $75.4M |
| Total current assets | $980.5M | $1.0B | $770.6M | $743.2M |
| Cost | $716.9M | $716.3M | $682.0M | $676.3M |
| Less: accumulated depreciation | $398.5M | $395.1M | $374.2M | $366.8M |
| Property, plant and equipment, net | $318.4M | $321.2M | $307.8M | $309.5M |
| Long-term deferred tax assets | $13.0M | $11.6M | $1.3M | $1.1M |
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | $8.2M | $8.1M | — | — |
| Intangible assets, net | $745.7M | $789.3M | $572.9M | $592.3M |
| Goodwill | $1.4B | $1.4B | $1.2B | $1.2B |
| Other assets | $93.3M | $97.9M | $103.7M | $103.8M |
| Total assets | $3.6B | $3.6B | $2.9B | $2.9B |
| Short-term borrowings | $193.9M | $249.5M | $247.6M | $267.4M |
| Accounts payable | $118.8M | $130.8M | $114.7M | $104.1M |
| Contract liabilities | $158.7M | — | — | — |
| Accrued liabilities | $199.5M | $358.1M | $225.7M | $233.4M |
| U.S. and foreign taxes on income | $21.9M | $24.3M | $21.9M | $14.2M |
| Total current liabilities | $692.8M | $762.7M | $609.9M | $619.1M |
| Long-term debt | $1.3B | $1.3B | $834.3M | $861.8M |
| Accrued pension and postretirement benefits | $28.7M | $27.8M | $21.6M | $21.5M |
| Long-term deferred tax liability | $204.8M | $212.3M | $149.9M | $153.6M |
| Other liabilities | $123.0M | $119.6M | $89.5M | $85.0M |
| Total liabilities | $2.3B | $2.4B | $1.7B | $1.7B |
| Redeemable Noncontrolling Interest, Equity, Carrying Amount | $20.7M | $21.1M | — | — |
| Preferred shares, par value $0.01; 5,000,000 shares authorized | 0 | 0 | 0 | 0 |
| Common shares, par value $1.00; 200,000,000 shares authorized | 72.4M | 72.4M | 72.4M | 72.4M |
| Capital surplus | $1.7B | $1.7B | $1.7B | $1.7B |
| Retained earnings | $395.6M | $370.6M | $336.3M | $295.5M |
| Accumulated other comprehensive loss | ($112.6M) | ($110.9M) | ($97.6M) | ($92.0M) |
| Treasury stock | ($801.2M) | ($802.3M) | ($812.2M) | ($813.7M) |
| Total shareholders’ equity | $1.3B | $1.2B | $1.2B | $1.2B |
| Nonredeemable noncontrolling interests | ($1.2M) | ($1.6M) | ($1.6M) | $1.8M |
| Total equity | $1.3B | $1.2B | $1.2B | $1.2B |
| Total liabilities, redeemable noncontrolling interests, and equity | $3.6B | $3.6B | $2.9B | $2.9B |
| Common shares issued (in shares) | 72.4M | 72.4M | 72.4M | 72.4M |
| Less: Common shares held in treasury (in shares) | 14.9M | 14.9M | 15.0M | 15.1M |
| Common shares outstanding (in shares) | 57.6M | 57.5M | 57.4M | 57.4M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income before allocation to noncontrolling interest | $145.1M | $184.1M | $188.3M | — |
| Loss (income) from equity investments | $11.5M | — | — | — |
| Depreciation and amortization | $106.6M | $86.8M | $77.6M | $118.9M |
| Stock-based compensation expense | $12.7M | $10.6M | $10.3M | $24.2M |
| (Gain) loss on forward contracts | ($4.7M) | $3.0M | — | — |
| Defined benefit plans and postretirement credit | ($800.0K) | ($2.1M) | ($1.1M) | ($1.3M) |
| Deferred income taxes | ($14.8M) | ($17.6M) | $7.6M | ($17.6M) |
| Cash used for operating working capital | ($17.0M) | ($50.6M) | $0 | $2.2M |
| Other | $2.9M | ($100.0K) | ($6.4M) | $18.6M |
| Total provided by operating activities | $241.5M | $214.1M | $276.3M | ($151.6M) |
| Payment for acquisitions, net of cash acquired | ($391.1M) | ($269.9M) | — | $0 |
| Purchase of investments | ($116.5M) | — | — | — |
| Capital expenditures | ($43.2M) | ($45.4M) | ($31.1M) | ($58.4M) |
| Settlement of forward contracts | $1.7M | ($2.7M) | — | — |
| Payments for (Proceeds from) Productive Assets | $100.0K | — | — | — |
| Total used for investing activities | ($549.0M) | ($318.0M) | ($31.1M) | $264.0M |
| Dividends paid | ($39.0M) | ($36.6M) | ($23.7M) | ($105.9M) |
| Proceeds from share subscriptions | 21.4M | — | — | — |
| Proceeds from stock options exercised | $2.6M | $3.3M | $4.4M | — |
| Payment of tax withholding on equity awards vested | ($6.2M) | ($6.9M) | — | — |
| Debt issuance costs | ($22.3M) | ($2.7M) | ($5.7M) | $0 |
| Repayment of long-term debt | $0 | $0 | ($300.0M) | — |
| Proceeds from revolving credit facility | $406.5M | $448.5M | $20.0M | $0 |
| Repayment of revolving credit facility | ($490.5M) | ($238.5M) | ($20.0M) | — |
| Proceeds from term loans | $532.0M | $0 | $350.0M | $399.4M |
| Repayment of term loan | ($40.9M) | ($105.0M) | ($245.0M) | $0 |
| Net transfers to Crane | $0 | $0 | ($32.5M) | — |
| Total provided by (used for) financing activities | $363.6M | $62.1M | ($252.5M) | $106.0M |
| Effect of exchange rates on cash, cash equivalents and restricted cash | $16.7M | ($12.0M) | $3.8M | ($39.4M) |
| Increase (decrease) in cash, cash equivalents and restricted cash | $72.8M | ($53.8M) | ($3.5M) | $179.0M |
| Cash, cash equivalents and restricted cash at beginning of period | $173.4M | $227.2M | $230.7M | $478.6M |
| Cash, cash equivalents and restricted cash at end of period | $246.2M | $173.4M | — | — |
| Accounts receivable | ($46.8M) | ($44.4M) | ($6.3M) | ($46.8M) |
| Inventories | $5.2M | $21.3M | ($1.0M) | ($54.7M) |
| Other current assets | ($16.4M) | ($9.0M) | $0 | ($8.0M) |
| Accounts payable | $5.9M | $5.7M | ($6.8M) | $53.3M |
| Accrued liabilities | $37.0M | ($28.4M) | ($2.5M) | $28.8M |
| U.S. and foreign taxes on income | ($1.9M) | $4.2M | $16.6M | $25.2M |
| Total | ($17.0M) | ($50.6M) | $0 | $2.2M |
| Interest paid | $55.6M | $44.1M | $45.1M | $47.6M |
| Income taxes paid, net | $50.9M | $63.8M | $46.0M | $147.2M |
| Unpaid capital expenditures | $2.5M | $7.2M | $7.1M | — |
| Non-cash investing activities | $21.3M | — | — | — |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income before allocation to noncontrolling interest | $43.0M | $6.8M | $97.6M | $46.7M |
| Depreciation and amortization | $68.5M | $29.7M | $77.7M | $48.7M |
| Stock-based compensation expense1 | $19.2M | $14.8M | $9.3M | $6.0M |
| Income from equity investments | ($4.8M) | ($4.7M) | — | — |
| Deferred income taxes | ($5.4M) | ($1.9M) | ($11.7M) | ($12.8M) |
| Cash used for operating working capital | $55.8M | $51.3M | $41.9M | $48.1M |
| Other | ($600.0K) | ($7.4M) | $4.7M | $3.2M |
| Total provided by operating activities | $72.7M | ($14.0M) | $135.7M | $43.7M |
| Proceeds from Sale of Productive Assets | $5.1M | $4.6M | — | — |
| Proceeds from disposition of assets | ($225.4M) | ($225.4M) | $391.1M | $394.0M |
| Capital expenditures | ($23.4M) | ($10.1M) | ($33.4M) | ($20.1M) |
| Settlement of forward contracts | $400.0K | ($300.0K) | $1.8M | $1.5M |
| Total used for investing activities | ($244.1M) | ($231.2M) | ($422.7M) | ($412.6M) |
| Dividends paid | ($20.7M) | ($10.3M) | ($29.2M) | ($19.5M) |
| Proceeds from stock options exercised | $300.0K | $0 | $2.2M | $1.3M |
| Purchase of noncontrolling interest | ($200.0K) | — | — | — |
| Payment of tax withholding on equity awards vested | ($3.0M) | ($2.8M) | ($5.9M) | ($5.8M) |
| Debt issuance costs | ($2.0M) | ($1.6M) | ($4.3M) | ($800.0K) |
| Repayment of short-term debt | ($115.1M) | — | — | — |
| Proceeds from revolving credit facility | $159.4M | $30.0M | $384.5M | $348.0M |
| Repayments of revolving credit facility | ($101.0M) | ($30.0M) | ($413.5M) | ($342.0M) |
| Proceeds from term loan | $366.9M | $366.9M | $400.4M | $400.4M |
| Repayment of term loan | ($112.4M) | ($112.4M) | ($40.9M) | ($36.8M) |
| Finance lease repayments | ($1.9M) | — | — | — |
| Total provided by financing activities | $170.3M | $239.8M | $293.3M | $344.8M |
| Effect of exchange rates on cash, cash equivalents and restricted cash | ($4.0M) | ($1.8M) | $15.1M | $15.2M |
| (Decrease) increase in cash, cash equivalents and restricted cash | ($5.1M) | ($7.2M) | $21.4M | ($8.9M) |
| Cash, cash equivalents and restricted cash at beginning of period2 | $246.2M | $246.2M | $173.4M | $173.4M |
| Cash, cash equivalents and restricted cash at end of period | $241.1M | $239.0M | $194.8M | $164.5M |
| Accounts receivable | ($8.3M) | ($9.0M) | $1.5M | $900.0K |
| Inventories | ($24.5M) | ($23.2M) | ($17.6M) | ($7.9M) |
| Other current assets | $2.7M | ($5.1M) | ($13.1M) | ($9.9M) |
| Accounts payable | ($35.7M) | ($26.8M) | ($10.9M) | ($23.8M) |
| Accrued liabilities | $23.7M | $19.9M | $3.8M | $11.9M |
| U.S. and foreign taxes on income | ($13.7M) | ($7.1M) | ($5.6M) | ($19.3M) |
| Interest paid | $35.0M | $15.9M | $40.6M | $25.7M |
| Income taxes paid, net | $33.1M | $11.2M | $48.1M | $42.2M |
| Unpaid capital expenditures | $2.0M | $2.7M | $1.3M | $2.4M |
| Current restricted cash | $2.7M | $3.7M | $2.6M | $900.0K |
| Noncurrent restricted cash | $7.0M | $7.0M | $9.8M | $11.1M |
| Long-term contract liabilities | $8.6M | — | — | — |
Crane NXT Co score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.